Skip to main navigation
Skip to search
Skip to main content
Ulster University Home
Home
Researchers
Research units
Projects
Research output
Student theses
Datasets
Activities
Press/Media
Prizes
Search by expertise, name or affiliation
Incretin hormone mimetics and analogues in diabetes therapeutics
Brian D. Green,
Peter Flatt
School of Biomedical Sciences
Faculty Of Life & Health Sciences
Research output
:
Contribution to journal
›
Article
›
peer-review
92
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Incretin hormone mimetics and analogues in diabetes therapeutics'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Antidiabetic Agent
16%
Clinical Trial
16%
Diabetes
100%
Dipeptidyl Peptidase IV
16%
Exenatide
33%
Gastric Inhibitory Polypeptide
66%
Glucagon
16%
Glucagon Like Peptide
100%
Gut
16%
Incretin
100%
Liraglutide
16%
Maturity Onset Diabetes of the Young
16%
Receptor
16%
Receptor Antagonist
16%
Pharmacology, Toxicology and Pharmaceutical Science
Antidiabetic Agent
16%
Clinical Trial
16%
Dipeptidyl Peptidase IV
16%
Exendin 4
33%
Gastric Inhibitory Polypeptide
33%
Gastric Inhibitory Polypeptide Receptor
33%
Glucagon
16%
Glucagon-Like Peptide-1
100%
Incretin
100%
Liraglutide
16%
Non Insulin Dependent Diabetes Mellitus
16%
Receptor Antagonist
16%